CLL Debate: BTKi and BCL2i Combinations in Frontline Treatment of CLL

from Medical News Podcast · host PeerDirect Publishing

Drs. Brander and Cohen discuss an ongoing debate in the management of CLL about BTK and BCL2 inhibitor combinations in the frontline treatment of CLL. Is it better to combine BTK and BCL2 inhibitors, or to start with one or the other as monotherapy?

Episode metadata supplied by the publisher feed · Published Jun 13, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

CLL Debate: BTKi and BCL2i Combinations in Frontline Treatment of CLL

0:00 8:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 8 minutes long.

When was this Medical News Podcast episode published?

This episode was published on June 13, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!